Bioavailability of Duloxetine 60 mg With Regards to Reference Product in Feeding Conditions
Status:
Completed
Trial end date:
2021-03-16
Target enrollment:
Participant gender:
Summary
This Study will investigate the bioavailability in fasting subjects of 1 capsule formulation
containing Duloxetine 60 mg. The Study will be performed at a single site with 36
subjects.Participants will take 1 capsule of the test product and reference product in 2
periods and 2 sequences (either test after reference or reference after test). There will be
a washout of at least 14 days between each study period.